United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10370-368_26ca9b31-f93f-4a92-8d13-651ade1e1c77
- Product NDC
- 10370-368
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Topiramate
- Labeler
- Par Health USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230324
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-01) · 10370-368-01
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-11) · 10370-368-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →